Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Achieve Life Sciences (ACHV) Change in Account Payables (2016 - 2026)

Achieve Life Sciences (ACHV) has disclosed Change in Account Payables for 15 consecutive years, with -$53000.0 as the latest value for Q1 2026.

  • Quarterly Change in Account Payables rose 81.91% to -$53000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$851000.0 through Mar 2026, down 166.28% year-over-year, with the annual reading at -$1.1 million for FY2025, 181.91% down from the prior year.
  • Change in Account Payables for Q1 2026 was -$53000.0 at Achieve Life Sciences, up from -$1.1 million in the prior quarter.
  • The five-year high for Change in Account Payables was $1.2 million in Q4 2022, with the low at -$1.1 million in Q4 2025.
  • Average Change in Account Payables over 5 years is -$3235.3, with a median of -$53000.0 recorded in 2026.
  • The sharpest move saw Change in Account Payables plummeted 394.96% in 2023, then surged 4795.0% in 2024.
  • Achieve Life Sciences' Change in Account Payables stood at $1.2 million in 2022, then plummeted by 101.63% to -$20000.0 in 2023, then surged by 4795.0% to $939000.0 in 2024, then tumbled by 215.44% to -$1.1 million in 2025, then soared by 95.11% to -$53000.0 in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Change in Account Payables are -$53000.0 (Q1 2026), -$1.1 million (Q4 2025), and $725000.0 (Q3 2025).